Search results
Kiora Pharmaceuticals director buys $25,668 in company stock By Investing.com
Investing.com· 11 hours agoOn June 13, 2024, Parsons acquired 5,260 shares of common stock at a price of $4.88 per share. This...
Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Down Following Insider Selling
ETF DAILY NEWS· 6 hours agoUltragenyx Pharmaceutical shares last traded at $43.72, with a volume of 62,032 shares trading hands. Specifically, EVP Karah Herdman Parschauer sold 9,806 shares of the & ...
Q2 2024 EPS Estimates for Longboard Pharmaceuticals, Inc. Cut by Analyst (NASDAQ:LBPH)
ETF DAILY NEWS· 6 hours agoLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – Equities research analysts at B. Riley dropped their Q2 2024 EPS estimates for Longboard Pharmaceuticals ...
Telomir Pharmaceuticals (NASDAQ:TELO) Trading 2.2% Higher
ETF DAILY NEWS· 5 hours agoTelomir Pharmaceuticals, Inc. (NASDAQ:TELO – Get Free Report) shares were up 2.2% during trading on Thursday . The stock traded as high as $6.28 and last traded at $5.63.
Euronext Paris Growth Companies With High Insider Ownership And Up To 40% Revenue Growth
Simply Wall St. via Yahoo Finance· 1 hour agoAmid a backdrop of mixed global economic signals, with some regions showing signs of growth and...
TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded to Buy by StockNews.com
ETF DAILY NEWS· 5 hours agoTRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday ...
Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 6 hours agoEquities researchers at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a note issued to investors on Friday. The firm ...
Pacira BioSciences COO sells shares worth $28,380 By Investing.com
Investing.com· 9 hours agoPacira BioSciences, Inc. (NASDAQ:PCRX), a pharmaceutical company specializing in non-opioid pain...
Ultragenyx Pharmaceutical (NASDAQ:RARE) Rating Reiterated by Cantor Fitzgerald
ETF DAILY NEWS· 5 hours agoUltragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Cantor Fitzgerald in a report released on ...
Insider Sale: SVP, Chief Technology Officer Silji Abraham Sells Shares of West Pharmaceutical ...
GuruFocus.com via Yahoo Finance· 8 hours agoOn June 12, 2024, Silji Abraham, Senior Vice President and Chief Technology Officer of West ...